Healthcare - Biotechnology - NASDAQ - US
$ 6.12
-3.32 %
$ 647 M
Market Cap
-5.06
P/E
INCOME STATEMENT
0
REVENUE
-144 M
OPERATING INCOME
-134 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Annexon, Inc.
| Revenue | 0 |
| Cost Of Revenue | 3.27 M |
| Gross Profit | -3.27 M |
| Operating Expenses | 144 M |
| Operating Income | -144 M |
| Other Expenses | -9.49 M |
| Net Income | -134 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 3.3 | 3.3 | 3.4 | 0.7 | 0.5 | 0.5 | 0.3 |
| Gross Profit | (3.3) | (3.3) | (3.4) | (0.7) | (0.5) | (0.5) | (0.3) |
| OPERATING INCOME | |||||||
| Operating Expenses | 143.7 | 145.6 | 130.7 | 63.5 | 32.5 | 19.1 | 20.2 |
| Selling, General and Administrative Expenses | 30.0 | 33.1 | 30.6 | 14.2 | 8.0 | 3.6 | 2.4 |
| Research and Development Expenses | 113.8 | 112.5 | 100.1 | 49.3 | 24.5 | 15.5 | 17.9 |
| Operating Income | (143.7) | (145.6) | (130.7) | (63.5) | (32.5) | (19.1) | (20.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 3.7 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 9.5 | 3.7 | 0.4 | 57 K | (4.7) | 0.8 | 1.8 |
| Pre-Tax Income | (134.2) | (141.9) | (130.3) | (63.4) | (37.2) | (18.3) | (18.7) |
| NET INCOME | |||||||
| Tax Provision | 0 | (3.7) | (2.5) | (0.7) | 4 K | 1 K | 1 K |
| Net Income | (134.2) | (138.3) | (127.8) | (62.7) | (37.2) | (18.3) | (18.7) |
| EPS | 1.77 | 2.53 | 3.34 | 3.7 | 0.97 | 1.6 | 0.49 |